Trial intelligence / Profile preview

Mifepristone and Misoprostol for Failed Medical Abortion

NCT02704481Phase 4Terminated

Sponsor
Gynuity Health Projects
Start
Jun 2016
Primary completion
Jan 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of mifepristone (2 arms), sponsored by Gynuity Health Projects. Primary endpoint: Successful abortion without surgical intervention at 1 week. Started Jun 2016; status: terminated.

02

Drugs

mifepristone

Beyond the preview

Go deeper on NCT02704481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02704481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call